EZH2 as a regulator of cell proliferation in pituitary tumors
Abstract: Pituitary adenomas are the most frequent intracranial neoplasms mainly benign in nature. However, they can occasionally lead to malignant endocrinopathies. Epigenetic modifications are described among the various factors proposed as guidelines for pituitary tumorigenesis. EZ...
Guardado en:
| Autores principales: | Zlocowski , N, Sosa, L, Torres, AL |
|---|---|
| Formato: | Artículo revista |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/34913 |
| Aporte de: |
Ejemplares similares
-
Regulation of pituitary tumors proliferation induced for the FGF2/FGFR1 pathway
por: Villafañe , FM, et al.
Publicado: (2021) -
Pérdida de la expresión del supresor tumoral pten en el desarrollo adenomatoso adenohipofisario
por: Toledo, J, et al.
Publicado: (2017) -
Expresión de componentes del fenotipo secretor asociado a senescencia en un modelo murino de tumor pituitario neuroendócrino
por: Ramírez, JY, et al.
Publicado: (2024) -
Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway
por: Petiti, Juan Pablo, et al.
Publicado: (2023) -
Combination of anti-proliferative signalling activation for the treatment of pituitary tumors
por: Picech, F, et al.
Publicado: (2019)